ConductScience.org, home

Paper36738564

Chemical language models for de novo drug design: Challenges and opportunities.

Grisoni F. Curr Opin Struct Biol, 2023. Cited by 82 papers, by iCite.

Cite this record

ConductScience Library. Chemical language models for de novo drug design: Challenges and opportunities. Papers, record 36738564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36738564

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemical language models for de novo drug design: Challenges and opportunities.
PubMed
Journal
Curr Opin Struct Biol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
10.1
iCite
Revised in PubMed
2023-03-23
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grisoni FFrancesca

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug DesignMajor topic
Drug DiscoveryMajor topic
Models, Chemical

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
42814605MMP2Mol: a matched molecular pairs-based framework for ligand-based de novo drug design.Brief Bioinform2026https://conductscience.org/library/papers/42814605PubMed
42780543Artificial intelligence-driven drug discovery: a deep learning paradigm shift in pharmaceutical research and development.Front Pharmacol2026https://conductscience.org/library/papers/42780543PubMed
42567977Artificial intelligence in drug discovery - what it is, where we stand and the path forward.Nat Rev Drug Discov2026https://conductscience.org/library/papers/42567977PubMed
42563013Why do AI projects fail in drug development and pharma? Insights from multi-year Pistoia Alliance studies.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42563013PubMed
42552350Diversity Beats Size Scaling for Chemical Language Models.NPJ Drug Discov2026https://conductscience.org/library/papers/42552350PubMed
42547887Transformers for molecular property prediction: domain adaptation efficiently improves performance.J Cheminform2026https://conductscience.org/library/papers/42547887PubMed
42519174ColdstartMHDTI: integrating biomolecular pretraining and attention-based heterogeneous graph learning for drug-target interaction prediction.Front Chem2026https://conductscience.org/library/papers/42519174PubMed
42450185Evaluating AI-Generated Molecules for Drug Discovery: From Generic Metrics to Translational Readiness.Int J Mol Sci2026https://conductscience.org/library/papers/42450185PubMed
42380605Quantum-machine-assisted drug discovery.NPJ Drug Discov2026https://conductscience.org/library/papers/42380605PubMed
42258020A round-robin exercise for the precise prediction of aqueous solubility of organic chemicals using chemometric, machine learning, and stacking ensemble of deep learning models.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42258020PubMed
42211383Data-driven design and screening of novel Klebsiella pneumoniae carbapenemase-2 β-lactamase inhibitors using a generative CLM.RSC Adv2026https://conductscience.org/library/papers/42211383PubMed
42115404SmileyLlama: modifying large language models for directed chemical space exploration.Nat Comput Sci2026https://conductscience.org/library/papers/42115404PubMed
42112265Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion Models.Proc AAAI Conf Artif Intell2026https://conductscience.org/library/papers/42112265PubMed
42083036Framework for evaluating explainable AI in antimicrobial drug discovery.J Cheminform2026https://conductscience.org/library/papers/42083036PubMed
42006255Fine-Tuning a Transformer Model for METTL3 Lead Optimization.ACS Bio Med Chem Au2026https://conductscience.org/library/papers/42006255PubMed
41965890Structural optimization of drug molecules with incrementally trained language models.Nat Commun2026https://conductscience.org/library/papers/41965890PubMed
41546836A large language model-guided reinforcement learning framework for EGFR anticancer drug design.J Comput Aided Mol Des2026https://conductscience.org/library/papers/41546836PubMed
41531766Explainable artificial intelligence for molecular design in pharmaceutical research.Chem Sci2026https://conductscience.org/library/papers/41531766PubMed
41441186AgentMol: Multi-Model AI System for Automatic Drug-Target Identification and Molecule Development.Methods Protoc2025https://conductscience.org/library/papers/41441186PubMed
41366732Application and Prospects of Large Language Models in Small-Molecule Drug Discovery.Anal Chem2025https://conductscience.org/library/papers/41366732PubMed

See all 57 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36738564

GET https://conductscience.org/api/papers/v1/36738564/cited_by?page=2